Skip to main content

Month: May 2024

Gevo’s Verity and ClearFlame Announce Transportation Decarbonization Collaboration

ENGLEWOOD, Colo., May 07, 2024 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO), along with its wholly owned subsidiary, Verity Holdings, LLC, (“Verity”), and ClearFlame Engine Technologies, Inc., (“ClearFlame”) announced today a collaboration to drive decarbonization traceability from field-to-fleet for the road freight transportation market in the United States, which consumes an estimated 29 billion gallons of fuel every year.  Under this collaboration, the parties intend to use Verity’s proprietary carbon accounting software to authenticate the carbon intensity (CI) of biofuels derived from crops grown on U.S. farms to their consumption in ClearFlame-equipped trucks. The Verity platform would track environmental attributes from field-to-fleet. At the field level, data regarding the greenhouse gas (GHG) emissions required to grow...

Continue reading

Varonis Adds AI Prompt Monitoring to Prevent Malicious Copilot Activity

Data security leader announces new capabilities to investigate risky Copilot interactions and stop AI-related data security breaches NEW YORK and SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) — RSA Conference 2024 Booth #5658 — Varonis Systems, Inc. (Nasdaq: VRNS), a leader in data security, today announced the addition of prompt monitoring to its Microsoft 365 Copilot security offering. This new feature allows security teams to investigate risky prompts, responses, and sensitive file references directly within the Varonis Data Security Platform. Generative AI tools can dramatically improve productivity, but attackers and rogue insiders can also weaponize the technology to gather and steal sensitive data quickly. The ability to quickly identify and mitigate prompt hacking is essential for clearing security roadblocks currently holding...

Continue reading

Mullen Announces Bollinger Motors Taps Amerit Fleet Solutions for Mobile Service and Warranty for the Company’s B4 All-Electric Class 4 Commercial Truck

BREA, Calif., May 07, 2024 (GLOBE NEWSWIRE) — via IBN — Mullen Automotive, Inc. (NASDAQ: MULN) (“Mullen” or the “Company”), an electric vehicle (“EV”) manufacturer, announces today its subsidiary, Bollinger Motors, and Amerit Fleet Solutions (“Amerit”), a leading provider of customized fleet maintenance and repair programs nationwide, have entered into an agreement for Amerit to provide mobile service and maintenance to Bollinger’s commercial fleet customers. Under the terms of the agreement, the two companies will jointly provide EV service and warranty support for the Bollinger B4 in key states allowed by law, as well as future vehicles developed by Bollinger Motors. The Bollinger B4 Chassis Cab is an all-new, all-electric Class 4 commercial truck designed from the ground up with extensive fleet and upfitter input. Bollinger’s...

Continue reading

Orezone Provides Notice of Q1-2024 Results and Conference Call

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone”) will announce its first quarter 2024 results on May 13, 2024 after market close. A conference call and audio webcast to discuss the results will take place on Tuesday, May 14, 2024, at 8:00 am PT (11:00 am ET).WebcastDate:   Monday, May 14, 2024Time:   8:00 am Pacific time (11:00 am Eastern time)Please register for the webcast here: Orezone Q1-2024 Conference Call and Webcast     Conference CallToll-free in U.S. and Canada: 1-800-715-9871International callers: +646-307-1963Event ID: 2084420 About Orezone Gold Corporation Orezone Gold Corporation (TSX: ORE OTCQX: ORZCF) is a West African gold producer engaged in mining, developing, and exploring its 90%-owned flagship Bomboré Gold Mine in Burkina...

Continue reading

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

SANTA CLARA, Calif., May 07, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, announced the first cases completed with the smaller, 9.5 mm diameter, iFuse Bedrock Granite® Implant (Granite 9.5). When placed across the SI joint, the Granite implant provides sacroiliac fusion and spinopelvic fixation as a foundational element for multi-segment spinal fusion. This milestone for Granite 9.5 comes after 510(k) clearance in January 2024. The iFuse Bedrock Granite Implant System was awarded a Breakthrough Device Designation by the Food & Drug Administration and a New Technology Add-on Payment by the Centers for Medicare and Medicaid Services. Granite 9.5 may be more suitable for patients with smaller anatomy...

Continue reading

Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare for Impact from the Inflation Reduction Act

New Medicare Part D inflation rebate enhancement helps pharma manufacturers manage pricing reforms SAN MATEO, Calif., May 07, 2024 (GLOBE NEWSWIRE) — Model N (NYSE: MODN), the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impending IRA regulation and avoid significant revenue loss. “The Inflation Reduction Act introduces sweeping changes for drug pricing and Medicare programs, and our goal is to empower customers to stay ahead of these shifts,” said Suresh Kannan, Chief Product Officer at Model N. “As our life sciences customers prepare for new reforms and regulatory...

Continue reading

ALX Oncology Appoints Allison Dillon as Chief Business Officer

SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology company developing therapies that block the CD47 immune checkpoint pathway, today announced the appointment of Allison Dillon, Ph.D., as Chief Business Officer (“CBO”). “We are excited to welcome Allison to our leadership team in the midst of this promising growth period for our Company,” said Jason Lettmann, Chief Executive Officer of ALX Oncology. “For over 15 years, Allison has worked to develop and deliver novel oncology products to patients with cancer. With multiple clinical study readouts over the next 12 months, Allison’s deep oncology market expertise and impressive track record in executing portfolio, development, and commercial strategy will be vital in our endeavor...

Continue reading

Edible Garden Announces Product Development Agreement with Hermann Pickle Company

R&D partnership focused on next-generation fermented product development Strategy to leverage Edible Garden’s credibility in produce for new product expansion BELVIDERE, NJ, May 07, 2024 (GLOBE NEWSWIRE) — Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally grown, organic, and sustainable produce and products, today announced that it has entered into a product development agreement (the “Agreement”) with Hermann Pickle Company LLC (“Hermann Pickles”), an industry leading company in the region that specializes in refrigerated kosher dill pickles, sauerkraut and fermented food products based in Garrettsville, Ohio. Under the Agreement, the parties intend to collaborate on the research and development of scalable commercial opportunities...

Continue reading

Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

SALT LAKE CITY, May 07, 2024 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the reorganization of its European operations to better align company resources to its domestic opportunities while continuing to serve key biopharma partners and patients outside the United States. As part of the reorganization, Myriad signed a definitive agreement to sell its EndoPredict® business to Eurobio Scientific, a leading French group in in vitro medical diagnostics and life sciences. Myriad will also license Eurobio the right to sell Prolaris in vitro diagnostic kits outside the U.S. Myriad will license the rights to continue to produce and sell EndoPredict, as a Laboratory Developed Test (LDT), in the U.S. as part of Precise Oncology Solutions, its comprehensive suite...

Continue reading

Mimecast Closes Strongest Expansion Year on Record

Expands leadership team with appointment of Chris Wey as Chief Transformation Officer LEXINGTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Mimecast, a global cybersecurity company, capped a year of robust growth with the largest new and expansion revenue gains in the company’s history.  Customers are responding positively to Mimecast’s strong product innovation and acquisition strategy. For example, the recently launched Cloud Integrated Email Security solution, designed to protect Microsoft 365 via robust API integration, has already onboarded customers in every global operating region. More than half of those customers have come through valued Managed Service Provider (MSP) partners. Additionally, the company has seen growth with its awareness training platform, and rapid adoption of its DMARC solution, which saw a 38% increase...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.